Ivomec Premix for Swine

Name: Ivomec Premix for Swine

Ivomec Premix for Swine Dosage and Administration

MIXING AND FEEDING DIRECTIONS FOR WEANED/GROWING/FINISHING PIGS

Add IVOMEC Premix (Type A Medicated Article) to starter, grower and finisher feeds at 300 g per ton to supply 1.8 g ivermectin per ton (2 ppm) of feed.

Use this Type C Medicated Feed as the only feed ad libitum for 7 consecutive days. This provides approximately 0.1 mg ivermectin per kg (2.2 lb) of body weight per day.

MIXING AND FEEDING DIRECTIONS FOR ADULT AND BREEDING ANIMALS

The recommended dose level for breeding animals is 0.1 mg ivermectin/kg body weight daily for seven consecutive days. Add IVOMEC Premix (Type A Medicated Article) to complete feed at 1.5 kg (3.3 lb) per ton to supply 9.1 g ivermectin per ton (10 ppm) of feed. Feed this Type C Medicated Feed at the rate of 1 lb (454 g) per 100 lb of body weight daily for seven consecutive days. On a daily basis, any additional non-medicated feed should not be given until the medicated feed is consumed. For heavy animals being fed less than 1% of their body weight per day, the ivermectin level in the Type C Medicated Feed can be up to 11.8 g per ton.

As sow feeding practices vary during the different phases of their reproductive cycle (i.e., limited feeding during gestation and ad libitum during lactation), the inclusion rate of ivermectin per ton of complete feed can be adjusted accordingly to obtain the 0.1 mg/kg treatment level.

As an example, the following inclusion rates for IVOMEC Premix w/w (Type A Medicated Article) based on body weight and feed intake are determined by the formula.

average body weight (lb) = lb of IVOMEC Premix (Type A Medicated Article) per ton of feed
average daily intake (lb) per head X 30
Average Body Weight (lb) Daily Feed Intake (lb) Premix (0.6%) per ton Type C Feed (lb) Ivermectin Level in Type C Feed (g/ton)
400 4.0 3.33 9.1
5.0 2.67 7.3
6.0 2.22 6.1
500 4.0 4.17 11.3
5.0 3.33 9.1
6.0 2.78 7.6

IVOMEC Premix (Type A Medicated Article) should be thoroughly and evenly mixed in the feed in accordance with good manufacturing practices for medicated feeds.

Dispersion of IVOMEC Premix in the feed is enhanced by diluting 1 part of this 0.6% Type A Medicated Article with 14 parts of finely ground feed ingredients to provide an intermediate premix.

Environmental safety

Studies show that when ivermectin comes in contact with the soil, it readily and tightly binds to the soil and becomes inactive over time. Free ivermectin may adversely affect fish and certain water-borne organisms on which they feed. Do not permit water runoff from swine production sites to directly enter lakes, streams or ponds. Do not contaminate water by direct application or by the improper disposal of drug containers. Dispose of containers in an approved landfill or by incineration.

Weaned/Growing/Finishing Pigs

All weaners/feeder pigs should be treated upon placement in clean quarters. Frequency of and need for additional treatments are dependent upon parasite exposure.

Adult and Breeding Animals

At the time of initiating any parasite control program, it is important to treat all animals in the herd. After the initial treatment, use IVOMEC Premix regularly as follows:

Sows: Treat, preferably, 14-21 days prior to farrowing to minimize parasitism of piglets.
Gilts: Treat, preferably, 14-21 days prior to breeding.
Treat, preferably, 14-21 days prior to farrowing.
Boars: Treat at least 2 times per year.
Frequency of and need for additional treatments are dependent upon parasite exposure.

NOTE: (1) Since the effect of ivermectin on mange mites is not immediate, avoid contact between treated pigs and mange-free pigs for approximately one week after completion of treatment. Exposure of treated pigs to mange-infected pigs may result in reinfestation.
(2) Louse eggs are unaffected by ivermectin and may require up to three weeks to hatch. Louse infestations developing from hatching eggs may require retreatment.

IVOMEC and Pig Head logo are registered trademarks of Merial Limited.
Copyright © 2007 Merial Limited. All Rights Reserved.

Merial Limited, a company limited by shares registered in England and Wales (registered number 3332751) with a registered office at PO Box 327, Sandringham House, Sandringham Avenue, Harlow Business Park, Harlow, Essex CM19 5QA, England, and domesticated in Delaware, USA as Merial LLC.

1023-1994-01
Rev. 05-2007

60005(US)
46316/180998A

Product 4128450

(web3)